Disulfiram Recruiting Phase 1 Trials for Solid Neoplasms / Pancreatic Adenocarcinoma Metastatic / Stage IV Pancreatic Cancer / Recurrent Pancreatic Carcinoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02671890Disulfiram and Gemcitabine Hydrochloride in Treating Patients With Unresectable Solid Tumors or Metastatic Pancreatic Cancer